These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 33124454)
1. Sexual function after vaginal erbium laser: the results of a large, multicentric, prospective study. Gambacciani M; Albertin E; Torelli MG; Bracco GL; Casagrande AC; Martella L; Baiocchi G; Alfieri S; Russo N; Cervigni M; Climacteric; 2020; 23(sup1):S24-S27. PubMed ID: 33124454 [TBL] [Abstract][Full Text] [Related]
2. Vaginal erbium laser as second-generation thermotherapy for the genitourinary syndrome of menopause: a pilot study in breast cancer survivors. Gambacciani M; Levancini M Menopause; 2017 Mar; 24(3):316-319. PubMed ID: 28231079 [TBL] [Abstract][Full Text] [Related]
3. Vaginal erbium laser: the second-generation thermotherapy for the genitourinary syndrome of menopause. Gambacciani M; Levancini M; Cervigni M Climacteric; 2015 Oct; 18(5):757-63. PubMed ID: 26029987 [TBL] [Abstract][Full Text] [Related]
4. Long-term effects of vaginal erbium laser in the treatment of genitourinary syndrome of menopause. Gambacciani M; Levancini M; Russo E; Vacca L; Simoncini T; Cervigni M Climacteric; 2018 Apr; 21(2):148-152. PubMed ID: 29436235 [TBL] [Abstract][Full Text] [Related]
5. Rationale and design for the Vaginal Erbium Laser Academy Study (VELAS): an international multicenter observational study on genitourinary syndrome of menopause and stress urinary incontinence. Gambacciani M; Torelli MG; Martella L; Bracco GL; Casagrande AG; Albertin E; Tabanelli S; Viglietta M; D'Ambrogio G; Garone G; Cervigni M Climacteric; 2015; 18 Suppl 1():43-8. PubMed ID: 26366800 [TBL] [Abstract][Full Text] [Related]
6. Short-term effects of an erbium/neodymium laser combination in superficial dyspareunia: a pilot study. Gambacciani M; Fidecicchi T Climacteric; 2022 Apr; 25(2):208-211. PubMed ID: 35006008 [TBL] [Abstract][Full Text] [Related]
7. Genitourinary syndrome of menopause (GSM) and laser VEL: a review. Elia D; Gambacciani M; Berreni N; Bohbot JM; Druckmann R; Geoffrion H; Haab F; Heiss N; Rygaloff N; Russo E Horm Mol Biol Clin Investig; 2019 Dec; 41(1):. PubMed ID: 31855563 [TBL] [Abstract][Full Text] [Related]
8. Short-term effect of vaginal erbium laser on the genitourinary syndrome of menopause. Gambacciani M; Levancini M Minerva Ginecol; 2015 Apr; 67(2):97-102. PubMed ID: 25763800 [TBL] [Abstract][Full Text] [Related]
9. Rationale and design for fractional microablative CO Flint R; Cardozo L; Grigoriadis T; Rantell A; Pitsouni E; Athanasiou S Climacteric; 2019 Jun; 22(3):307-311. PubMed ID: 30676818 [TBL] [Abstract][Full Text] [Related]
10. Safety and long-term efficacy of fractional CO Behnia-Willison F; Sarraf S; Miller J; Mohamadi B; Care AS; Lam A; Willison N; Behnia L; Salvatore S Eur J Obstet Gynecol Reprod Biol; 2017 Jun; 213():39-44. PubMed ID: 28419911 [TBL] [Abstract][Full Text] [Related]
11. Intraurethral Erbium:YAG laser for the management of urinary symptoms of genitourinary syndrome of menopause: A pilot study. Gaspar A; Maestri S; Silva J; Brandi H; Luque D; Koron N; Vižintin Z Lasers Surg Med; 2018 Oct; 50(8):802-807. PubMed ID: 29667744 [TBL] [Abstract][Full Text] [Related]
12. Patient-reported sexual function of breast cancer survivors with genitourinary syndrome of menopause after fractional CO2 laser therapy. Quick AM; Zvinovski F; Hudson C; Hundley A; Evans C; Stephens JA; Arthur E; Ramaswamy B; Reinbolt RE; Noonan AM; VanDeusen JB; Wesolowski R; Stover DG; Williams NO; Sardesai SD; Faubion SS; Loprinzi CL; Lustberg MB Menopause; 2021 Feb; 28(6):642-649. PubMed ID: 33534429 [TBL] [Abstract][Full Text] [Related]
13. Safety of vaginal erbium laser: A review of 113,000 patients treated in the past 8 years. Gambacciani M; Cervigni M; Gaspar A; Novakov Mikić A; Gaviria J; Koron N; Vizintin Z Climacteric; 2020; 23(sup1):S28-S32. PubMed ID: 33124457 [No Abstract] [Full Text] [Related]
14. The Er:YAG vaginal laser for management of women with genitourinary syndrome of menopause (GSM). Lin KL; Chou SH; Loo ZX; Liu YY; Cheng JC; Long CY Lasers Med Sci; 2022 Jun; 37(4):2203-2208. PubMed ID: 34988731 [TBL] [Abstract][Full Text] [Related]
15. Superficial dyspareunia treatment with hyperstacking of erbium:yttrium-aluminum-garnet SMOOTH laser: a short-term, pilot study in breast cancer survivors. Fidecicchi T; Gaspar A; Gambacciani M Menopause; 2023 Feb; 30(2):174-178. PubMed ID: 36696641 [TBL] [Abstract][Full Text] [Related]
16. Efficacy of Two Laser Treatment Strategies for Breast Cancer Survivors With Genitourinary Syndrome of Menopause. Okui N; Okui M; Kouno Y; Nakano K; Gambacciani M Cureus; 2023 May; 15(5):e38604. PubMed ID: 37284382 [TBL] [Abstract][Full Text] [Related]
17. Laser Therapy for Genitourinary Syndrome of Menopause. Rabley A; O'Shea T; Terry R; Byun S; Louis Moy M Curr Urol Rep; 2018 Aug; 19(10):83. PubMed ID: 30117032 [TBL] [Abstract][Full Text] [Related]
18. The effect of vaginal erbium laser treatment on sexual function and vaginal health in women with a history of breast cancer and symptoms of the genitourinary syndrome of menopause: a prospective study. Arêas F; Valadares ALR; Conde DM; Costa-Paiva L Menopause; 2019 Sep; 26(9):1052-1058. PubMed ID: 31453969 [TBL] [Abstract][Full Text] [Related]
19. The effects of fractional microablative CO Gittens P; Mullen G J Cosmet Laser Ther; 2019; 21(3):127-131. PubMed ID: 29883233 [TBL] [Abstract][Full Text] [Related]
20. Sexual Function in Women Suffering From Genitourinary Syndrome of Menopause Treated With Fractionated CO Salvatore S; Pitsouni E; Del Deo F; Parma M; Athanasiou S; Candiani M Sex Med Rev; 2017 Oct; 5(4):486-494. PubMed ID: 28843942 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]